Abbrea Capital LLC Purchases 200 Shares of The Procter & Gamble Company (NYSE:PG)

Abbrea Capital LLC grew its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 0.4% in the fourth quarter, HoldingsChannel.com reports. The fund owned 55,587 shares of the company’s stock after acquiring an additional 200 shares during the period. Procter & Gamble makes up 1.2% of Abbrea Capital LLC’s investment portfolio, making the stock its 22nd largest position. Abbrea Capital LLC’s holdings in Procter & Gamble were worth $8,146,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Cardinal Capital Management boosted its holdings in shares of Procter & Gamble by 1.0% in the 3rd quarter. Cardinal Capital Management now owns 48,489 shares of the company’s stock valued at $7,073,000 after buying an additional 494 shares during the last quarter. Altus Wealth Management LLC raised its stake in Procter & Gamble by 0.5% in the 3rd quarter. Altus Wealth Management LLC now owns 30,579 shares of the company’s stock valued at $4,460,000 after acquiring an additional 144 shares during the period. First Affirmative Financial Network raised its stake in Procter & Gamble by 21.3% in the 3rd quarter. First Affirmative Financial Network now owns 5,103 shares of the company’s stock valued at $744,000 after acquiring an additional 895 shares during the period. Bridge Creek Capital Management LLC raised its stake in Procter & Gamble by 1.0% in the 3rd quarter. Bridge Creek Capital Management LLC now owns 42,367 shares of the company’s stock valued at $6,180,000 after acquiring an additional 437 shares during the period. Finally, Buttonwood Financial Advisors Inc. raised its stake in Procter & Gamble by 3.4% in the 3rd quarter. Buttonwood Financial Advisors Inc. now owns 9,765 shares of the company’s stock valued at $1,424,000 after acquiring an additional 322 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction on Monday, January 29th. The stock was sold at an average price of $156.00, for a total transaction of $7,020,000.00. Following the completion of the transaction, the chief executive officer now owns 973 shares in the company, valued at $151,788. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Ma. Fatima Francisco sold 45,000 shares of Procter & Gamble stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $156.00, for a total value of $7,020,000.00. Following the completion of the sale, the chief executive officer now directly owns 973 shares in the company, valued at $151,788. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 28,369 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 100,865 shares of company stock worth $16,029,280. 0.17% of the stock is owned by insiders.

Procter & Gamble Stock Down 0.8 %

Shares of NYSE PG traded down $1.26 during mid-day trading on Friday, hitting $161.29. 5,594,614 shares of the stock traded hands, compared to its average volume of 6,956,219. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $164.32. The company has a market cap of $380.67 billion, a price-to-earnings ratio of 26.30, a PEG ratio of 3.30 and a beta of 0.44. The stock has a fifty day moving average price of $159.57 and a 200-day moving average price of $153.39.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same period in the previous year, the company posted $1.37 earnings per share. The firm’s revenue was up .6% on a year-over-year basis. Research analysts anticipate that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $1.0065 per share. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. Procter & Gamble’s payout ratio is presently 65.85%.

Wall Street Analyst Weigh In

PG has been the topic of several recent research reports. Barclays increased their price objective on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday. Argus increased their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Thursday. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and increased their target price for the stock from $160.00 to $175.00 in a report on Monday, March 11th. Deutsche Bank Aktiengesellschaft reduced their target price on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a report on Monday. Finally, The Goldman Sachs Group initiated coverage on Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective on the stock. Seven investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $169.76.

View Our Latest Analysis on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.